{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:57:54Z","timestamp":1791215874795,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":322,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2001,2]]},"abstract":"<jats:p>Nerve growth factor (NGF) has been shown to increase cyclic AMP in PC12 cells and to potentiate the actions of other agents that raise cyclic AMP. In our studies, NGF causes over 50% loss of PDE 2 activity (cyclic GMP\u2010stimulated cyclic nucleotide phosphodiesterase) in PC12 cells within 24\u2003h. After 72\u2003h of NGF treatment, cyclic AMP hydrolysis in PC12 extracts is no longer cyclic GMP\u2010stimulated. NGF deprivation increases the phosphodiesterase activity of treated cells. NGF does not decrease either PDE 2 mRNA or immunoreactivity of PDE 2A2 protein. Incubation of whole cells with micromolar Na<jats:sub>3<\/jats:sub>VO<jats:sub>4<\/jats:sub> mimics NGF treatment, reducing PDE 2 activity in PC12 cells by over 50% after 24\u2003h, suggesting a phosphoprotein\u2010mediated regulation of PDE 2 activity. Protein kinase inhibitor effects were difficult to assess due to their direct interaction with the PDE in cell lysates. To study phosphorylation in PDE 2 regulation, PDE 2A2 was epitope\u2010tagged, and stable clonal PC12 cell transfectants were isolated (PC12B cells). When combined with metabolically labeled <jats:sup>32<\/jats:sup>P\u2010phosphoproteins <jats:italic>in vivo<\/jats:italic> or <jats:italic>in vitro<\/jats:italic>, phosphoproteins of 108, 90, 64, 43, 33 and 19\u2003kDa coprecipitated with epitope\u2010tagged PDE 2A2 in an NGF sensitive manner. A 23\u2010kDa phosphoprotein containing immunoreactive phosphoserine associated with the complex in an NGF independent manner. Phosphothreonine plus phosphotyrosine immunoreactivity at 23, 24, and 64\u2003kDa as well as the phosphotyrosine immunoreactivity at 108, 90, 64, 43, 33, and 19\u2003kDa required NGF or orthovanadate treatment. These proteins are hypothesized to be part of an NGF\u2010regulated complex controlling PDE 2A2 activity.<\/jats:p>","DOI":"10.1046\/j.1471-4159.2001.00133.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:51:18Z","timestamp":1047451878000},"page":"1252-1263","source":"Crossref","is-referenced-by-count":12,"title":["Nerve growth factor inhibits PC12 cell PDE 2 phosphodiesterase activity and increases PDE 2 binding to phosphoproteins"],"prefix":"10.1111","volume":"76","author":[{"given":"J. Kelley","family":"Bentley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.","family":"Juilfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Uhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1523\/JNEUROSCI.05-05-01176.1985","article-title":"Nerve growth factor treatment enhances nicotine\u2010stimulated dopamine release and increases in cyclic adenosine 3\u2032 : 5\u2032\u2010monophosphate levels in PC12 cell cultures","volume":"5","author":"Baizer L.","year":"1985","journal-title":"J. Neurosci."},{"key":"e_1_2_7_3_1","doi-asserted-by":"crossref","first-page":"18676","DOI":"10.1016\/S0021-9258(19)37014-0","article-title":"Molecular cloning of cDNA encoding a \u201863\u2019\u2010kDa calmodulin\u2010stimulated phosphodiesterase from bovine brain","volume":"267","author":"Bentley J. K.","year":"1992","journal-title":"J. Biol. Chem."},{"key":"e_1_2_7_4_1","first-page":"328","volume-title":"Methods in Neurosciences","author":"Boulter J.","year":"1989"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.69031300.x"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.1.288"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(97)00149-0"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(91)01043-2"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.73.7.2424"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(87)47111-5"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-4388(99)00010-0"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.89.2.240"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.6.3485"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(93)80012-J"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.100.3.916"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-4547(19970215)47:4<427::aid-jnr8>3.3.co;2-1"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.58.4.659"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.7.3388"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0959-4388(00)00092-1"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5397.2275"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(93)81382-A"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.9.6038"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi00474a010"},{"key":"e_1_2_7_24_1","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/mol.57.4.738","article-title":"Differential inhibition of multiple cAMP phosphodiesterase isozymes by isoflavones and tyrphostins","volume":"57","author":"Nichols M. R.","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0169-328x(98)00315-5"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/0898-6568(95)00042-n"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(93)90364-L"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.286.5448.2358"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/24884"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0378-1119(97)00046-2"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/002215549904700707"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.1.231"},{"key":"e_1_2_7_33_1","first-page":"231","article-title":"Measurement of protein using bichinchoninic acid","volume":"175","author":"Smith P. K.","year":"1985","journal-title":"Anal. Biochem."},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0955-0674(99)00073-3"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)47421-8"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)54354-4"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0076-6879(90)85008-C"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0167-4889(88)90105-X"},{"key":"e_1_2_7_39_1","first-page":"711","article-title":"Phosphodiesterase II, the cGMP\u2010activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells","volume":"39","author":"Whalin M. E.","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_7_40_1","first-page":"184","article-title":"Optimization of asymmetric polymerase chain reaction for rapid fluorescent DNA sequencing","volume":"8","author":"Wilson R. K.","year":"1990","journal-title":"Biotechnology"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.41.25699"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1994.2886"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.14.8240"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/33451"}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1471-4159.2001.00133.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1471-4159.2001.00133.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T09:25:03Z","timestamp":1697621103000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1471-4159.2001.00133.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,2]]}},"alternative-id":["10.1046\/j.1471-4159.2001.00133.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00133.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,2]]}}}